This inventor holds 1 USPTO granted patent. Top assignee: Hadasit Medical Research Services and Development Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Etti Ben-shushan: Innovator in Oligodendrocyte Research
Introduction
Etti Ben-shushan is a prominent inventor based in Jerusalem, Israel. She has made significant contributions to the field of medical research, particularly in the generation of oligodendrocytes, which are crucial for the proper functioning of the nervous system. Her innovative methods have the potential to impact the treatment of various neurological diseases.
Latest Patents
Etti holds a patent for her groundbreaking work titled "Methods of generating oligodendrocytes." This patent describes a method for generating human mature oligodendrocytes by contacting a cell population that includes human pre-oligodendrocytes with an inhibitor of the MAPK/ERK pathway. The conditions set forth in her method allow for the differentiation of pre-oligodendrocytes into mature oligodendrocytes. Additionally, the use of the MAPK/ERK pathway inhibitor for treating diseases is also disclosed in her patent. Etti has 1 patent to her name.
Career Highlights
Etti Ben-shushan is associated with Hadasit Medical Research Services and Development Ltd., where she continues her research and development efforts. Her work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.
Collaborations
Etti collaborates with Benjamin Eithan Reubinoff, a fellow researcher in the field. Their partnership exemplifies the collaborative spirit of scientific inquiry and innovation.
Conclusion
Etti Ben-shushan's contributions to oligodendrocyte research highlight her role as a leading inventor in the medical field. Her innovative methods and dedication to advancing science are paving the way for new treatments for neurological diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile